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Summary 
The natural, non-toxic antifouling compound zosteric acid (ZA, p-coumaric acid 
sulfate) was encapsulated in polystyrene (PS) microcapsules (30 mg Z N l  g PS) with 
an efficiency of 30 % via an in-liquid drying process. Electron micrographs showed 
microcapsules with smooth surfaces and a mean diameter of 200 pm. The FIB method 
was used to cross-section a microcapsule in order to visualize the inner capsule 
structure and to localize ZA via element analysis. Coatings of a biocompatible 
polyester, poly[3-hydroxyalkanoate-co-3-hydroxyalkenoate] (PHAE), were prepared 
on microscopic slides. These coatings contained dispersed ZA (PHAEIZA) or ZA- 
loaded PS microcapsules (PHAE/PS(ZA)). The release of ZA was monitored via 
conductivy measurements in water and was 4 pgcm-2d-' for PHAEIZA and 0.9 
pgcm-2d-' for PHAE/PS(ZA) coatings. To follow the initial steps of biofilm formation, 
coated slides were exposed to activated sludge and analyzed for cell adhesion with 
ESEM. ZA was effective during the burst release time of the PHAE/ZA coating, but 
no significant differences in biofouling were observed after 48 h. This was attributed 
to the minimal effective release rate of ZA, which is approximately 10 pgcm-2d-'. 
Introduction 
Marine plants are constantly exposed to harmful attacks by bacteria, spores or fungi 
building biofilms on the plant surfaces. In order to protect themselves some plants 
developed repulsion mechanisms, e.g. the seagrass Zostera marina L.  (eelgrass). The 
eelgrass produces and continuously releases the water-soluble (8 % (wiw) in water) 
antifouling compound zosteric acid (ZA), p-coumaric acid sulfate. This antifoulant 
does not kill microorganisms but inhibits their adhesion through binding to attachment 
sites on cell surfaces at non-toxic concentrations [ 1-41. 
The aim of our investigation was to mimic this non-toxic protection strategy in 
combination with a biocompatible surface, namely a coating of poly[3- 
hydroxyalkanoate-co-3-hydroxyalkenaote], (PHAE). These polyesters have gained 
considerable significance in medical and industrial applications, which include 
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implant materials, scaffolds in tissue engineering, and packaging. ZA was blended 
with PHAE directly or, to control the release rate, encapsulated in polystyrene and 
embedded in PHAE, followed by preparation of coatings. Microcapsules have been 
widely used, e.g. in pharmacy for drug delivery [j]. Several techniques have been 
developed to produce microparticulate release systems for water-soluble drugs, 
including the solvent evaporation method [6-121, interfacial reaction techniques [ 13- 
161, and suspensioil/dispersion methods [17-191. Here, we report on the successful 
encapsulation of ZA into polystyrene via the solvent evaporation method and on the 
characterization of these microcapsules. The preparation of PHAE coatings and 
release investigations are described. Finally, the adhesion of biological organisms on 
unprotected PHAE coatings, PHAE with dispersed ZA, and PHAE with encapsulated 
ZA are compared. 
Experimental 
Materials 
Bacterial poly[3-hydroxyalkanoate-co-3 -hydroxyalkenaote] (PHAE; Scheme la) with 
10 % side-chain double bonds (Mn- 90'000 g/mol, Mw- 210'000 g/mol, calibration 
with PS-standar4 Tg = -40 "C) was synthesized with Pseudomoizas putida GPol 
(ATCC 29347) in chemostat cultures under multiple nutrient limited growth 
conditions [20,2 I]. ZA was obtained from R. C. Zimmermann, Moss Landing Marine 
Laboratories, Moss Landmg CA, USA. Polystyrene (Mw- 23O'OOO g/mol, Mn- 
140'000 g/mol, Tg = 94 "C) was obtained from Aldnch and poly(viny1 alcohol) (PVA 
3-98, Mw- 16'000 g/mol) from Fluka. All other reagents were used as purchased 
form Aldrich or Fluka. 
Scheme 1 : a) Poly[3-hydroxyalkanoate-co-3-hydroxyalkenaote] (PHAE); m= 0.1; n= 0.9; x= 2 ,  
4,6; y= 2,4.  b) Zosteric acid@-coumaric acid sulfate). 
Instruments 
The particle size distribution of the microcapsules was measured with a Beckman 
coulter particle size analyzer LS230. The morphology examination and the elementary 
analysis of the microcapsules surfaces were carried out with a LEO electron 
microscopy 1455, equipped with an Oxford Instruments EDS system at 10 kV. 
Therefore, the samples were coated with a 5 nm Pt-layer using a BAL-TEC MED 020 
Coating System. Cross-sections of the microcapsules were prepared by a dual beam 
focused ion beam (FIB) milling techque  with a FEI Strata DB 235 field emission 
scanning electron microscope (FEG-SEM; &+-ions at 30 kV and 1000 PA). P m -  
coatings were applied with a Sogolee HP-200 air brush at 2-3 bar. Photographs of 
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polished cross-sections of PHAE coatings, which were fixed in epoxy resin, were 
taken with an Axiovert lOOA (Zeiss) system. The release of ZA was monitored via 
conductivity by a WTW inoLab pWCond Level3 with a WTW TetraCon 325 probe 
and a MultiLab pilot program. The biofilm formation was visually analyzed with an 
environmental electron microscope (Amray Eco-SEM 3200 C) at 150 Ton and 20 "C. 
Preparation of microcapsules and coatings 
Microcapsules were prepared via an "in-liquid-drying process" in a temperature 
controlled reactor of 250 mL equipped with an impeller stirrer. For the oil in water 
(OW)-emulsion, 4 g of PS was dissolved in 16 mL methylene chloride. Subsequently, 
400 mg ZA was &spersed into this solution with an Ultra Turrax (24'000 rpm, 1 min 
under ice cooling). This dispersion was then poured into 160 mL deionized water 
containing 2 % (w/w) PVA under stirring (2'000 rpm) at 20 "C for 4 h. Solid 
microcapsules were filtrated, washed with deionized water, and dned under reduced 
pressure. 
Sandblasted microscope slides (area 20 cm2) were used as substrates for all coatings. 
PHAE coatings containing encapsulated ZA were prepared in three steps. First, a 
PHAE solution (1 g PHAE dissolved in 10 mL methylene chloride) was sprayed onto 
microscope slides with an air brush. Second, after short drying, microcapsules (about 
150 mg per slide) were evenly spread on these sticky PHAE surfaces with a small 
brush. Finally, an additional layer of PHAE was applied to cover the microcapsules. 
For the preparation of PHAE coatings containing dispersed ZA, 100 mg ZA was 
dispersed in a PHAE solution (1 g PHAE dissolved in 10 mL methylene chloride) 
with an Ultra Turrax (24'000 rpm, 1 min under ice cooling). This dispersion was 
sprayed onto microscope slides with an air brush. After application, all coatings were 
dried under reduced pressure at 40 "C for 12 h. 
Determination of the antifoulant content and its release 
The loading of ZA in the microcapsules was determined by weighmg. The loaded 
microcapsules were dissolved in methylene chloride, ZA was extracted with water, 
followed by freeze drying and weighmg. The leachmg of ZA from the PHAE coatings 
was monitored by conductivity measurements. Therefore, the coated microscope 
slides were stored in Millipore water (80 mL) in a completely closed glass tube. A 
calibrated conductivity probe recorded the release of ZA at 23 "C. 
Determination of cell adhesion 
The initial steps of biofilm forination (cell adhesion and attachment) were assessed in 
a 5 L glass beaker with pretreated, activated sludge. Test coupons were glued with 
silicone to the inner wall at equal heights in order to guarantee identical test 
conditions. Activated sludge was settled for 30 min and the supernatant was discarded. 
The sediment was homogenized with an Ultra T m x  at 24'000 rpm for 4 min and 
resuspended with a filter sterilized salt solution to the original volume. One liter of 
salt solution contained 85 mg KH2PO4, 217.5 mg K2HP04, 266 mg Na2HP04, 25 mg 
m C 1 ,  22.5 mg MgS04*7H20, 27.5 mg CaC12, and 0.25 mg FeC13*6H20 in 
demineralized water. The biomass content of the culture was determined by weight 
measurements and was 4.6 gL-'. The test coupons were exposed to t h s  sludge for 48 
68 
h. The coupons were sampled with a tweezers, dipped in sterile 0.9 % (w/v> NaC1, and 
stored in 2.5 % glutaraldehyde at 4 "C until further analysis by ESEM. 
Results and discussion 
Characterization of the microcapsules 
This work demonstrated that the in-liquid-drymg process was successful to 
encapsulate the hydrophilic sodium salt of ZA in a lipophilic PS matrix. Due to the 
high viscosity of the PSIZA dispersion, the salt was hindered to completely dissolve in 
the water phase of the OW-emulsion during the microcapsule formation and 
hardening. The particle size measurement of the microcapsules revealed a 
monomodal, relatively narrow size distribution with a mean capsule diameter of 200 
pm (Figure 1). The surfaces of the capsules were smooth without failures proven by 
SEM (Figure 2). 
0.1 1 10 loo 1m 
Particle Diameter I lun 
Figure 1. Particle size distsibution of PS 
microcapsules, the mean diameter is 200 pm 
Figure 2. Electron micrograph of PS 
microcapsules. 
The encapsulation efficiency of water-soluble compounds is generally low [5, 61. We 
determined, after dissolution of the microcapsules in methylene chloride followed by 
water-extraction of ZA, a loading of 3 % (w/w) ZA in polystyrene capsules. This 
corresponds to 30 % of the maximum loading, given by the amounts of ZA (400 mg) 
and PS (4 g) used in the production process. 
We were interested to know where ZA was localized inside the microcapsule and to 
visualize the inner microcapsule structure. Common methods to open microcapsules 
are freeze-fracture with following SEM investigations [S, 61. We used the FIB method 
to cross-section a microcapsule. This method has become only recently an important 
tool for semiconductor device modification, as well as local micro-cross sectioning. 
An advantage of FIB cross-sectioning is that it can be carried out under permanent 
SEM control and that the Ga+-ion beam produces smooth cross-sections in the 
submicrometer range. Figurc 3a shows an electron micrograph of a cross-section of a 
microcapsule cut by FIB. Although the P€IAE/ZA dispersion was treated with 
ultrasound in order to remove air bubbles, the core of the PS capsule contained still 
empty caverns. No ZA crystals could be detected inside the microcapsule. The cross- 
sectioned microcapsule was therefore transferred to a SEM with EDS system for 
sulfur and sodium elemental analysis. The brighter areas in the electron backscatter 
images gave first hints of the existence of heavier elements (Figure 3b). Quantitative 
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element mapping with the EDS system (Figures 3c,d) clarified the position of sulfur 
and sodium and proved the existence of encapsulated ZA. Maps of carbon or oxygen 
were not conclusive, mainly due to the low ZA loading 
Figure 3. a) Electron micrograph of a microcapsule cross-section prepared by FIB milling, b) 
electron backscatter image, c) sulfur element map of the cross-section region, d) analogous 
sodium element map. 
P M E  coatings and release 
ZA encapsulated microcapsules were embedded in a PHAE coating (named 
PHAEDJS(ZA)). Figure 4a shows this coating applied to an objective slide (area 20 
cm2, approximately 4.5 mg ZA per slide), and Figure 4b its cross-section, 
respectively. The film thickness was about 450 pm. In contrast, the film thickness of 
the PHAE coating with dispersed ZA (named PHAEIZA) was only about 50 pm 
(approximately 10 mg ZA per slide). Two slides of PHAEPS(ZA) and one slide of 
PHAE/ZA were separately immersed in Millipore water (80 mL), and the release of 
ZA was monitored by changes in the water conductivity. In keeping with the biofilm 
formation experiments (see below), Figure 5 displays the time-course of the 
conductivity of both PHAE coatings for the initial 48 h. After a burst release, 
observable by a short increase of the conductivity during the fast few hours, 
encapsulated ZA was released at an almost constant rate. After 48 h the release (per 
slide) of dispersed ZA was nearly four times than the release of encapsulated ZA. Due 
to the high glass transition temperature and the hydrophilicity of PS, the leaching of 
ZA out of the coating was hindered. On the other hand, the pure PHAE coating, which 
has a low glass transition temperature, had a smaller barrier effect against water. 
Overall, 0.9 pgcm-’d*’ encapsulated ZA and 4 pgcm-2d-’ dispersed ZA were released. 
This corresponds to approximately 0.8 % and 1.6 YO of ZA applied. For longer 
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periods, the conductivities increased regularly. After 5 days, some slides showed signs 
of film peeling and the release measurements were finished. 
Figure 4. a) Photograph of a PHAE/PS(ZA) coating with embedded microcapsules, b) cross- 
section of this coating with a film thickness of about 450 pm. 
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Figure 5. Release of ZA &om the PHAE coatings with embedded microcapsules 
(PHAE/PS(ZA)) and with dispersed ZA (PHAEIZA) monitored by changes in the water 
conductivity. 
Bio91m formation 
To examine the mode of action, biofilm formation experiments on protected and 
unprotected PHAE coatings were carried out. Therefore, PHAE, PKAE/PS(ZA) and 
PHAE/ZA coatings were exposed to diluted activated sludge in an aerated tank reactor 
over 48 h, a period suffcient to follow the attachment of microorganisms and the 
initial stages of biofilm formation [22]. Electron micrographs of o r i w  coatings and 
after 48 h are shown in Figure 6. Before exposure, the PHAE and PHAE/PS(ZA) 
coatings (Figures 6a and 6e) showed both smooth and undamaged surfaces. Small 
pores and elevations were visible for the PHAE/ZA coating in Figure 6c. They can be 
attributed to ZA crystals located near the surface; these crystals dissolved during the 
first three hours in contact with water and small craters were formed (Figure 6d). In 
contrast, the unprotected and microcapsules containing coating surfaces remained 
unchanged (Figures 6b, 6f). The extent of cell adhesion on the three coatings after 48 
h is comparable and the unprotected PHAE surface (Figure 6b) showed not sigdicant 
more bacterial settlement than the coatings containing ZA (Figure 6d, Sf). This can be 
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explained with the low ZA release rates determined for these coatings. The minimal 
effective release rate (MERR) of ZA is approximately 10 - 50 pgcm-’d-’ [3], 
considerably higher than the 0.9 pgcm-’d-’ found for the PHAE/PS(ZA) coating. 
Therefore, a substantial reduction in bacterial settlement should not be expected for 
this coating. On the other hana the release rate for the PHAE/ZA coating was 4 pgcm- 
d- , only slightly lower than the MEER This agrees with the observation that during 
the first 2 h no cell attachment was observed on this coating. During this time of the 
burst release (Figure 5), the leaching rate was considerable higher and the antifouling 
2 1  
properties of ZA became evident. 
a) b’l 
Figure 6. ESEM micrographs of original coatings and coatings after 48 h of exposure to 
activated sludge; a) and b) unprotected PHAE coating, c) and d) PHAE coating with dispersed 
24, e)  and f) PHAE coating with encapsulated ZA; in b), d) and f )  biological organisms are 
observable as small parhcles covering the coating surfaces. 
Conclusion 
Conventional strategies to remove a biofilm or protect a surface use highly toxic 
compounds that are aimed at killing the microorganisms. However, these antifoulants 
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are often also toxic to non-target organisms, can be accumulated through food chain 
amplification and cause environmental damage. This work demonstrates first results 
towards a more environmentally safe way to control biofouling. The flux of 
encapsulated ZA was lower than the minimal effective release rate. However, for ZA 
dispersed in PHAE, the antifouling effect was apparent during the first 2 hours of the 
burst release. Therefore, the encapsulation process and the loading with ZA have to be 
adjusted. If the size of the capsules is reduced, the increase of the capsule surface 
would presumably lead to a corresponding increase in the release rate. With the 
capsule being small enough (nanocapsules), it could even come close to the rate of the 
burst release of the ZA dispersion. Also, the PHAE hydrophilic-hydrophobic balance 
and the improvement of the coating adhesion are further steps to be optimized. 
Therefore, parts of the PHAE side-chain double bonds will be transformed into 
hydrophilic carboxyl or hydroxyl groups 1231, and the remaining double bonds in the 
coatings cross-linked through irradiation. 
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